EPICS is a drug discovery and development company that invents and develops small molecule drugs targeting RNA epigenetic mechanisms involved in cancer development. EPICS’s mission is to utilize its expertise in drug discovery and development to invent novel clinical agents targeting serious unmet medical needs in oncology. We develop products to meet high value-added endpoints. We constantly balance risk and reward in determining if and when to partner our programs.
Company Details
- Employees
- 28
- Founded
- -
- Address
- 47 Adrienne Bolland, Gosselies,wallonie 6041,belgium
- Phone
- +32 71 348 500
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- epicstherapeutics.com
- HQ
- Gosselies, Wallonie
Epics Therapeutics Questions
Epics Therapeutics's helpline number is +32 71 348 500
Epics Therapeutics's website is epicstherapeutics.com
Epics Therapeutics's LinkedIn profile is https://be.linkedin.com/company/epics-therapeutics
Epics Therapeutics has
28 employees.
View email and phone details for 28
employees at Epics Therapeutics.
Epics Therapeutics's industry is
Biotechnology Research
Epics Therapeutics's top competitors are
Aboleris Pharma,
Theratrame,
Santero Therapeutics,
Quantoom Biosciences,
Gynaia,
Signatur Biosciences,
Esobiotec,
Quidditas,
Iteos Therapeutics,
Astrivax Therapeutics.
Epics Therapeutics's support email address is info@epicstherapeutics.com
Epics Therapeutics's categories are Biotechnology Research
Epics Therapeutics's founding year is 2018
